About Chorda Pharma
Chorda Pharma is a private company based in Roanoke, Virginia. It has reported $492,500 raised in two offerings on Form D since February 2022. Its chief executive is Victor Iannello.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 6, 2024 | Dec 20, 2024 | $200,000of $600K target | 4 | $50,000 | Convertible Promissory NotesRule 506(b) | Form D ↗ |
| Dec 17, 2021 | Feb 1, 2022amended Apr 26, 2022 | $292,500of $500K target | 13 | $22,500 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $492,500 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Chorda Pharma's Form D filed Dec 20, 2024.
GJ
George Vaughan, Jr.
Director
AH
Aileen Helsel
Director
RC
Richard Carliss
Executive officer, director and promoter
JI
John Williamson III
Director
VI
Victor Iannello
Chief Executive Officer and director
Earlier filings also listed Troy Keyser (director, last listed Apr 2022) and Robert Vaughn (director, last listed Apr 2022).